Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients
2012 · BMC Research Notes · 40 citations
https://doi.org/10.1186/1756-0500-5-551
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
3.4K
Citations
26
h-index
39
i10-index
Miriam Lenhard is an academic researcher from Ludwig-Maximilians-Universität München. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Estrogen and related hormone effects & Reproductive System and Pregnancy. The author has an h-index of 26, co-authored 44 publications.
https://doi.org/10.1186/1756-0500-5-551
https://doi.org/10.1186/1471-2407-13-616
Click to start Chat